Clinical Trials Directory

Trials / Completed

CompletedNCT00783185

Dual Diagnosis (Psychosis and Cannabismisuse): Comparison of Specialized Treatment Versus Unspecified Treatment

Dual Diagnosis Psychosis and Substance Abuse: Short- and Middle-term Changes in Symptomatology After Visiting a Group Education Programme to Reduce Consumption of Cannabis

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
University of Konstanz · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Intention of the study is to examine, if the symptomatology of dual diagnosis patients is less severe after a special indication training for reduction of cannabis consumption in comparison to unspecified trainings. Point of interest is psychopathology and consumerism.

Detailed description

Dual diagnosis patients (psychosis and cannabis abuse) account for more clinical admissions than single diagnosis patients. Cannabis misuse is a known risk factor for recurrence of psychosis. A specified intervention on the basis of a manual for schizophrenic substance abusers is administered to inpatients in a specialized unit for young schizophrenic patients in a psychiatric hospital. The control group, same indication (psychotic disorder and cannabis misuse) receives social competence training (specified for schizophrenic patients as well). Admission to groups is randomly.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCannabis-Consumption-Reduction-Training8 sessions within 4 weeks (twice a week, 45 minutes each) Cognitive behavioral therapy with focus on cannabis abuse
BEHAVIORALSocial competence Training8 sessions within 4 weeks (twice a week, 45 minutes) training to develop and ameliorate social competences

Timeline

Start date
2006-01-01
Primary completion
2009-06-01
Completion
2010-01-01
First posted
2008-10-31
Last updated
2010-01-12

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00783185. Inclusion in this directory is not an endorsement.